3 Reasons Why Netflix Fears Are Overblown

3 Reasons Why Netflix Fears Are Overblown

Image source: Netflix. We could be eyeing a summer of dissed content at Netflix (NASDAQ:NFLX). Two third-party reports are suggesting that the loyalty of longtime subscribers is being challenged by the streaming platform’s move to begin charging both new and old customers the same $9.99-a-month rate. Subscribers who were paying $7.99 a month in early 2014 were → Read More

Best Dividend Mutual Funds for 2016

Best Dividend Mutual Funds for 2016

Image source: Getty Images. Disappointed with the income generated by your investment portfolio? You’re not alone. Through mid-September, investors socked away nearly $10.2 billion into dividend-focused funds, hoping to earn higher yields from their investment portfolios. But where many funds promise high yields, not all live up to their mission. High yield mutual funds frequently → Read More

Apple Pay on the Web Is a Game Changer

Apple Pay on the Web Is a Game Changer

Apple Pay on the Web. Image source: Apple. Remember in the late ’90s when PayPal (NASDAQ:PYPL) first launched, and its big feature was being able to pay for things on the internet with just an email address and password? In the nearly two decades since, PayPal has grown to become a massive player in online → Read More

Smith & Wesson's Most Popular Rifle Has a Big Problem

Smith & Wesson's Most Popular Rifle Has a Big Problem

The Smith & Wesson M&P 15-22 Sport, introduced earlier this year, has quickly gained in popularity because of its size, power, and lower cost, but is there a design flaw that needs to be corrected? Image source: Smith & Wesson. Smith & Wesson Holding (NASDAQ:SWHC) has a problem with one of its most popular rifles → Read More

Sorry Apple Inc. Fans — Don't Get Too Excited About the iPhone 7

Sorry Apple Inc. Fans — Don't Get Too Excited About the iPhone 7

Image Source: Apple. The launch of Apple‘s (NASDAQ:AAPL) latest smartphone has lit a fire under the stock. It was widely assumed prior to the announcement of the iPhone 7 and 7 Plus that the devices would bring incremental improvements with no major new features compelling Apple’s installed base to upgrade — and that’s exactly what Apple → Read More

Here's Why Your Social Security Check Is Hardly Going to Budge in 2017

Here's Why Your Social Security Check Is Hardly Going to Budge in 2017

Image source: Getty Images. As of July 2016, 60.5 million Americans were receiving Social Security payments each month, including 40.8 million retired workers. Among those retired workers, based on data straight from the Social Security Administration (SSA), 61% were counting on Social Security to provide at least half of their monthly income. As you might → Read More

What Investors Missed in the Market This Week

What Investors Missed in the Market This Week

Image source: Getty Images. Markets appeared to breathe a big sigh of relief when the Federal Reserve announced it would hold interest rates for the time being, but that it was still confident in the economy and a rate rise could come by year’s end — stop me if you’ve heard that before. But that → Read More

Disney World Hopes to Food & Wine a Turnaround

Disney World Hopes to Food & Wine a Turnaround

Image source: Disney. It’s that time of year when adults behave like children at Central Florida’s theme parks. Comcast‘s (NASDAQ:CMCSA) Universal Orlando kicked off Halloween Horror Nights last weekend where grown-ups scream, run, and clutch hands as they work their way through elaborate haunted houses and scare zones. Disney‘s (NYSE:DIS) Epcot kicked off its annual Food & → Read More

13 Amazing John D. Rockefeller Quotes to Change Your Life

13 Amazing John D. Rockefeller Quotes to Change Your Life

John D. Rockefeller by John Singer Sargent. Image source: Wikimedia Commons.  He is said to have been the richest, most famous self-made man who’s ever lived. Attracting the ire of peers, politicians, workers, and competitors, his name has become synonymous with extreme wealth and monopolistic business practices. That’s right — we’re speaking of the founder of Standard → Read More

Biotech Stocks Under $5: 2 to Buy, 1 to Avoid

Biotech Stocks Under $5: 2 to Buy, 1 to Avoid

Biotech stocks with share prices under $5 are generally too dangerous to own. Even so, some of these dirt-cheap biotechs can, on rare occasion, represent compelling growth opportunities for risk-tolerant investors. With this in mind, here’s a look at why you may want to buy Amarin Corp. (NASDAQ:AMRN) and Geron Corp. (NASDAQ:GERN), but avoid MannKind → Read More

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.